Insider Transactions Reported by 24 Insiders of Metacrine, Inc.

Location: San Diego, CA

Key facts

Metacrine, Inc. has 24 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are not currently available.

Change

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 26 May 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Metacrine, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Braden M. Leonard	10%+ Owner	$3,177,468	Mixed	19 Dec 2022
Scott D. Sandell	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Carmen Chang	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Ali Behbahani	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Anthony A. Florence Jr.	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Mohamad Makhzoumi	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Peter W. Sonsini	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Forest Baskett	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
New Enterprise Associates 16, L.P.	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
Paul Edward Walker	10%+ Owner	$1,204,731	Mixed	10 Dec 2021
venBio Global Strategic Fund, L.P.	10%+ Owner	$1,148,408	Mixed	22 Oct 2021
Preston Klassen	Director	$650,535	Mixed	23 Mar 2023
Trisha Millican	Chief Financial Officer	$51,249	Mixed	05 May 2021
Michael York	Chief Business Officer	$48,645	Mixed	26 Jan 2023
Catherine C. Lee	EVP, Gen. Counsel & Secretary	$1,808	Mixed	05 May 2021
Hubert C. Chen	Chief Medical Officer	$1,546	Mixed	20 May 2021
John G. McHutchison	Director		Mixed	18 May 2022
Amir Nashat	Director, 10%+ Owner		Mixed	18 May 2022
Richard A. Heyman	Director		Mixed	18 May 2022
Ronald M. Evans	Director		Mixed	18 May 2022
Kristina Burow	Director		Mixed	24 May 2021
Jeffrey David Jonker	Director		Mixed	18 May 2022
Andrew Guggenhime	Director		Mixed	18 May 2022
Julia C. Owens	Director		Mixed	18 May 2022

Top shareholders of Metacrine, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Braden M. Leonard	3/4/5	10%+ Owner	— class O/S missing	6,760,570	$3,177,468	—	19 Dec 2022	3/4/5
Ali Behbahani	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Anthony A. Florence Jr.	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Carmen Chang	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Forest Baskett	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Mohamad Makhzoumi	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
New Enterprise Associates 16, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Paul Edward Walker	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Peter W. Sonsini	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
Scott D. Sandell	3/4/5	10%+ Owner	— class O/S missing	2,563,257	$1,204,731	—	10 Dec 2021	3/4/5
venBio Global Strategic Fund, L.P.	3/4/5	10%+ Owner	— class O/S missing	2,443,421	$1,148,408	—	22 Oct 2021	3/4/5
Amir Nashat	3/4/5	Director, 10%+ Owner	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
Preston Klassen	3/4/5	Director	— class O/S missing	1,384,116	$650,535	—	23 Mar 2023	3/4/5
Trisha Millican	3/4/5	Chief Financial Officer	— class O/S missing	109,040	$51,249	—	05 May 2021	3/4/5
Michael York	3/4/5	Chief Business Officer	— class O/S missing	103,499	$48,645	—	26 Jan 2023	3/4/5
Catherine C. Lee	3/4/5	EVP, Gen. Counsel & Secretary	— class O/S missing	3,846	$1,808	—	05 May 2021	3/4/5
Hubert C. Chen	3/4/5	Chief Medical Officer	— class O/S missing	3,289	$1,546	—	20 May 2021	3/4/5
Andrew Guggenhime	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
Jeffrey David Jonker	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
John G. McHutchison	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
Julia C. Owens	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
Kristina Burow	3/4/5	Director	— class O/S missing	16,500	—	—	24 May 2021	3/4/5
Richard A. Heyman	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5
Ronald M. Evans	3/4/5	Director	— class O/S missing	16,500	—	—	18 May 2022	3/4/5

Recent Insider Transactions by Companies or Individuals for Metacrine, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.